Close
4

Quotient Sciences Quotient Sciences

X

CAS 1000669-72-6 manufacturers and suppliers on PharmaCompass

PharmaCompass
  • Chemistry
CAS 1000669-72-6
Also known as: Kw-2449, 1000669-72-6, Kw 2449, Kw2449, 841258-76-2, [4-[(e)-2-(1h-indazol-3-yl)ethenyl]phenyl]-piperazin-1-ylmethanone
Molecular Formula
C20H20N4O
Molecular Weight
332.4  g/mol
InChI Key
YYLKKYCXAOBSRM-JXMROGBWSA-N
FDA UNII
2D9N67F58G

FLT3/ABL/Aurora Kinase Inhibitor KW-2449 is an orally available inhibitor of FMS-related tyrosine kinase 3 (FLT3, STK1, or FLK2), the tyrosine kinase ABL, and aurora kinases, with potential antineoplastic activity. Upon administration, FLT3/ABL/Aurora kinase inhibitor KW-2449 specifically binds to and inhibits both wild-type and mutated forms of FLT3, ABL and aurora kinases, which both interferes with the activation of signal transduction pathways mediated by these kinases and reduces the proliferation of susceptible cancer cells. FLT3 and ABL kinases are upregulated in certain tumor cells and play important roles in tumor cell proliferation and metastasis. Aurora kinases, serine-threonine kinases overexpressed by a wide variety of cancer cell types, play essential roles in mitotic checkpoint control.
1 2D Structure

CAS 1000669-72-6

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[4-[(E)-2-(1H-indazol-3-yl)ethenyl]phenyl]-piperazin-1-ylmethanone
2.1.2 InChI
InChI=1S/C20H20N4O/c25-20(24-13-11-21-12-14-24)16-8-5-15(6-9-16)7-10-19-17-3-1-2-4-18(17)22-23-19/h1-10,21H,11-14H2,(H,22,23)/b10-7+
2.1.3 InChI Key
YYLKKYCXAOBSRM-JXMROGBWSA-N
2.1.4 Canonical SMILES
C1CN(CCN1)C(=O)C2=CC=C(C=C2)C=CC3=NNC4=CC=CC=C43
2.1.5 Isomeric SMILES
C1CN(CCN1)C(=O)C2=CC=C(C=C2)/C=C/C3=NNC4=CC=CC=C43
2.2 Other Identifiers
2.2.1 UNII
2D9N67F58G
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Kw 2449

2. Kw-2449

3. Kw2449

2.3.2 Depositor-Supplied Synonyms

1. Kw-2449

2. 1000669-72-6

3. Kw 2449

4. Kw2449

5. 841258-76-2

6. [4-[(e)-2-(1h-indazol-3-yl)ethenyl]phenyl]-piperazin-1-ylmethanone

7. Chembl1908397

8. 2d9n67f58g

9. [4-[2-(1h-indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone

10. Methanone, [4-[2-(1h-indazol-3-yl)ethenyl]phenyl]-1-piperazinyl-

11. (4-((1e)-2-(1h-indazol-3-yl)ethenyl)phenyl)-1-piperazinylmethanone

12. Piperazine, 1-(4-((1e)-2-(1h-indazol-3-yl)ethenyl)benzoyl)-

13. Methanone, (4-(2-(1h-indazol-3-yl)ethenyl)phenyl)-1-piperazinyl-

14. Kw-2449 Hydrochloride

15. Mls006011271

16. Unii-2d9n67f58g

17. Gtpl5691

18. Schembl1596894

19. Schembl1596897

20. Chebi:91441

21. Kw 2449 [who-dd]

22. Dtxsid701026046

23. Bcp02848

24. Ex-a2306

25. 897016-82-9 (free Base)

26. Bdbm50355496

27. Mfcd18385006

28. Nsc759675

29. Nsc800778

30. S2158

31. Zinc43201999

32. Akos027460993

33. Bcp9000826

34. Ccg-267833

35. Cs-0231

36. Nsc-759675

37. Nsc-800778

38. Ncgc00346569-07

39. 841259-17-4

40. Ac-28419

41. As-71712

42. Hy-10339

43. Smr004703021

44. Sw219852-1

45. H11584

46. J-502761

47. (e)-1-{4-[2-(1h-indazol-3-yl)vinyl]benzoyl}piperazine

48. (4-(2-(1h-indazol-3-yl)vinyl)phenyl)(piperazin-1-yl)methanone

49. 3-{2-[4-(piperazine-1-carbonyl)phenyl]ethenyl}-1h-indazole

50. 3-[(e)-2-{4-[(piperazin-1-yl)carbonyl]phenyl}ethenyl]-2h-indazole

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 332.4 g/mol
Molecular Formula C20H20N4O
XLogP32.7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count3
Exact Mass332.16371127 g/mol
Monoisotopic Mass332.16371127 g/mol
Topological Polar Surface Area61 Ų
Heavy Atom Count25
Formal Charge0
Complexity480
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY